Are U.S. Health Care Program Drug Prices Based on “Competitive Market-Derived Prices”?
Recent U.S. free trade agreements have included language regulating the way in which member countries manage their pharmaceutical drug coverage…
The 340B Program is Not Exempt from the US-Korea Free Trade Agreement
The U.S. has recently begun to include in free trade agreements provisions regarding government health care programs which reimburse entities…
Do Free Trade Agreement Pharmaceutical Chapters Promote “Off-Label” Marketing?
Recent free trade agreements with Korea and Australia have included provisions regulating pharmaceutical reimbursement programs operated at the “central level…
New Trend in Free Trade Agreements Could Affect U.S. Health Care Programs
As the latest round of negotiations for the Trans Pacific Partnership (TPP) free trade agreement starts this week in Vietnam,…
The TPP Free Trade Agreement May Affect the Medicare Part B Program
The U.S. has recently begun to include in free trade agreements provisions regarding government health care programs which reimburse entities…